Urinary bladder cancer risk factors in an area of former coal, iron, and steel industries in Germany

References

• Bell, D. A., Taylor, J. A., Paulson, D. F., Robertson C. N., Mohler J. L., and Lucier G. W. 1993. Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85: 1159–1164.
   PubMed Web of Science ®Google Scholar
• Bolt, H. M., and Golka, K. 2007. The debate on carcinogenicity of permanent hair dyes: New insights. Crit. Rev. Toxicol. 37: 521–536.
   PubMed Web of Science ®Google Scholar
• Bolt, H. M., and Thier, R. 2006. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr. Drug Metab. 7: 613–628.
   PubMed Web of Science ®Google Scholar
• Brennan, P., Bogillot, O., Cordier, S., Greiser, E., Schill, W., Vineis, P., Lopez-Abente, G., Tzonou, A., Chang-Claude, J., Bolm-Audorff, U., Jöckel, K. H., Donato, F., Serra, C., Wahrendorf, J., Hours, M., T´Mannetje, A., Kogevinas, M., and Boffetta, P. 2000. Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case-control studies. Int. J. Cancer 86: 289–294.
   PubMed Web of Science ®Google Scholar
• Cartwright, R. A., Glashan, R. W., Rogers, H. J., Ahmad, R. A., Barham-Hall, D., Higgins, E., and Kahn, M. A. 1982. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer. Lancet 2: 842–845.
   PubMed Web of Science ®Google Scholar
• Ciotti, M., Lakshmi, V. M., Basu, N., Davis, B. B., Owens, I. S., and Zenser, T. V. 1999. Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides. Carcinogenesis 20: 1963–1969.
   PubMed Web of Science ®Google Scholar
• Cordier, S., Clavel, J., Limasset, J. C., Boccon-Gibod, L., Le Moual, N., Mandereau, L., and Hemon D. 1993. Occupational risks of bladder cancer in France: a multicenter case-control study. Int. J. Epidemiol. 22: 403–411.
   PubMed Web of Science ®Google Scholar
• DGUV Deutsche Gesetzliche Unfallversicherung e. V. (DGUV). 2014. Aromatische Amine Eine Arbeitshilfe in Berufskrankheiten-Feststellungsverfahren: Report der Unfallversicherungsträger und des IFA 3. aktualisierte Auflage des BK-Reports 1/2009. Berlin: DGUV.
   Google Scholar
• Epidemiologic Cancer Registry NRW. 2013. Bladder cancer mortality in men in the federal state of North Rhine-Westfalia in 2011. Available at http://www.krebsregister.nrw.de/index.php?id=116 ( accessed April 28, 2016).
   Google Scholar
• Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., and Bray, F. 2014. GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. Available at http://globocan.iarc.fr ( accessed January 16, 2015).
   Google Scholar
• Freedman, N. D., Silverman, D. T., Hollenbeck, A. R., Schatzkin, A., and Abnet, C. C. 2011. Association between smoking and risk of bladder cancer among men and women. J. Am. Med. Assoc. 306: 737–745.
   PubMed Web of Science ®Google Scholar
• Ginsberg, G., Smolenski, S., Hattis, D., Guyton, K. Z., and Sonawane, B. 2009. Genetic polymorphism in glutathione S-transferases (GST): Population distribution of GSTM1, T1 and P1 conjugating activity. J. Toxicol. Environ. Health B 12: 389–439.
   PubMed Web of Science ®Google Scholar
• Golka, K., Abreu-Villaca, Y., Anbari Attar, R., Angeli-Greaves, M., Aslam, M., Basaran, N., Belik, R., Butryee, C., Dalpiaz, O., Dzhusupov, K., Ecke, T. H., Galambos, H., Gerilovica, H., Gerullis, H., Gonzalez, P. C., Goossens, M. E., Gorgishvili-Hermes, L., Heyns, C. F., Hodzic, J., Ikoma, F., Jichlinski, P., Kang, B. H., Kiesswetter, E., Krishnamurthi, K., Lehmann, M. L., Martinova, I., Mittal, R. D., Ravichandran, B., Romics, I., Roy, B., Rungkat-Zakaria, F., Rydzynski, K., Scutaru, C., Shen, J., Soufi, M., Toguzbaeva, K., Vu Duc, T., Widera, A., Wishahi, M., and Hengstler, J. G. 2012. Bladder cancer documentation of causes: Multilingual questionnaire, ‘bladder cancer doc’. Front. Biosci. (Elite Ed) 4: 2809–2822.
   PubMedGoogle Scholar
• Golka, K., Selinski, S., Lehmann, M. L., Blaszkewicz, M., Marchan, R., Ickstadt, K., Schwender, H., Bolt, H. M., and Hengstler, J. G. 2011. Genetic variants in urinary bladder cancer: Collective power of the “wimp SNPs”. Arch. Toxicol. 85: 539–554.
   PubMed Web of Science ®Google Scholar
• Golka, K., Prior, V., Blaszkewicz, M., and Bolt, H. M. 2002. The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: A review considering ethnic differences. Toxicol. Lett. 128: 229–241.
   PubMed Web of Science ®Google Scholar
• Golka, K., Bandel, T., Schlaefke, S., Reich, S. E., Reckwitz, T., Urfer, W., Bremicker, K.-D., Neugebauer, W., Soekeland, J., and Bolt, H. M. 1998. Urothelial cancer of the bladder in an area of former coal, iron, and steel industries in Germany: A case-control study. Int. J. Occup. Environ. Health 4: 79–84.
   PubMedGoogle Scholar
• Golka, K., Wiese, A., Assennato, G., and Bolt H. M. 2004. Occupational exposure and urological cancer. World J. Urol. 21: 382–391.
   PubMed Web of Science ®Google Scholar
• Golka, K., Reckwitz, T., Kempkes, M., Cascorbi, I., Blaskewicz, M., Reich, S. E., Roots, I., Sökeland, J., Schulze, H., and Bolt, H. M. 1997. N-Acetyltransferase 2 (NAT2) and glutathione S-transferase μ (GSTM1) in bladder-cancer patients in a highly industrialized area. Int. J. Occup. Environ. Health 3: 105–110.
   PubMedGoogle Scholar
• Gong, M., Dong, W., Shi, Z., Xu, Y., Ni, W., and An, R. 2012. Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: A meta-analysis of 57 studies. PLoS One 7: e50587.
   Google Scholar
• Guha, N., Steenland, N. K., Merletti, F., Altieri, A., Cogliano, V., and Straif K. 2010. Bladder cancer risk in painters: a meta-analysis. Occup. Environ. Med. 67: 568–573.
   PubMed Web of Science ®Google Scholar
• Hu, D. G., Mackenzie, P. I., McKinnon, R. A., and Meech, R. 2016. Genetic polymorphisms of human UDP-glucuronosyltransferase (UGT) genes and cancer risk. Drug Metab. Rev. 48: 47–69.
   PubMed Web of Science ®Google Scholar
• Hung, R. J., Boffetta, P., Brennan, P., Malaveille, C., Hautefeuille, A., Donato, F., Gelatti, U., Spaliviero, M., Placidi, D., Carta, A., Scotto di Carlo, A., and Porru, S. 2004. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int. J. Cancer 110: 598–604.
   PubMed Web of Science ®Google Scholar
• IARC International Agency for Research on Cancer. 2010. Some aromatic amines, organic dyes, and related exposures (IARC Monographs on the Evaluation of the Carcinogenetic Risk to Humans, Vol 99). Lyon. Available at http://monographs.iarc.fr/ENG/Monographs/PDFs/index.php (accessed April 24, 2016).
   Google Scholar
• Izumi, K., Zheng, Y., Hsu, J. W., Chang, C., and Miyamoto, H. 2013. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: A potential mechanism of androgen-induced bladder carcinogenesis. Mol. Carcinogen. 52: 94–102.
   PubMed Web of Science ®Google Scholar
• Kempkes, M., Golka, K., Reich, S., Reckwitz, T., and Bolt, H. M. 1996. Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder. Arch. Toxicol. 71: 123–126.
   PubMed Web of Science ®Google Scholar
• Kopps, S., Angeli-Greaves, M., Blaszkewicz, M., Prager, H. M., Roemer, H. C., Lohlein, D., Weistenhofer, W., Bolt, H. M., and Golka, K. 2008. Glutathione S-transferase P1 ILE105Val polymorphism in occupationally exposed bladder cancer cases. J. Toxicol. Environ. Health A 71: 898–901.
   PubMed Web of Science ®Google Scholar
• Li, N., and Stephens, M. 2003. Modelling linkage disequilibrium, and identifying recombination hotspots using SNP data. Genetics 165: 2213–2233.
   PubMed Web of Science ®Google Scholar
• Lin, G. F., Guo, W. C., Chen, J. G., Qin, Y. Q., Golka, K., Xiang, C. Q., Ma, Q. W., Lu, D. R., and Shen, J. H. 2005. An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China. Toxicol. Sci. 85: 502–506.
   PubMed Web of Science ®Google Scholar
• Mackenzie, P. I., Bock, K. W., Burchell, B., Guillemette, C., Ikushiro, S., Iyanagi, T., Miners, J. O., Owens, I. S., and Nebert, D. W. 2005. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet. Genom. 15: 677–685.
   PubMed Web of Science ®Google Scholar
• Noon, A. P., Pickvance, S. M., and Catto, J. W. 2012. Occupational exposure to crack detection dye penetrants and the potential for bladder cancer. Occup. Environ. Med. 69: 300–301.
   PubMed Web of Science ®Google Scholar
• Olsen, J. H., and Jensen,O. M. 1987. Occupation and risk of cancer in Denmark. An analysis of 93,810 cancer cases, 1970–1979. Scand. J. Work Environ. Health 13 (Suppl 1): 1–91.
   PubMed Web of Science ®Google Scholar
• Ovsiannikov, D., Selinski, S., Lehmann M. L., Blaszkewicz, M., Moormann O., Haenel, M. W., Hengstler, J. G., and Golka, K. 2012. Polymorphic enzymes, urinary bladder cancer risk, and structural change in the local industry. J. Toxicol. Environ. Health A 75: 557–565.
   PubMed Web of Science ®Google Scholar
• Pesch, B., Halekoh, U., Ranft, U., Richter, M., and Pott, F. 1994. Atlas zur Krebssterblichkeit NRW. Düsseldorf, Germany: Ministerium für Arbeit, Gesundheit und Soziales NRW.
   Google Scholar
• Reulen, R. C., Kellen, E., Buntinx, F., Brinkman, M., and Zeegers, M. P. 2008. A meta-analysis on the association between bladder cancer and occupation. Scand. J. Urol. Nephrol. 42(Suppl. 218): 64–78.
   Google Scholar
• Robert Koch Institute (RKI) and the Association of Population-based Cancer Registries in Germany. 2014. Cancer in Germany 2009/2010. 9th Edition. Berlin. Available at http://www.rki.de/Krebs/EN/Content/Publications/Cancer_in_Germany/cancer_chapters_2009_2010/cancer_germany_2009_2010.pdf?__blob=publicationFile (accessed November 29, 2014).
   Google Scholar
• Rothman, N., Garcia-Closas, M., Chatterjee, N., Malats, N., Wu, X., Figueroa, J. D., Real, F. X., Van Den Berg, D., Matullo, G., Baris, D., Thun, M., Kiemeney, L. A., Vineis, P., De Vivo, I., Albanes, D., Purdue, M. P., Rafnar, T., Hildebrandt, M. A., Kiltie, A. E., Cussenot, O., Golka, K., Kumar, R., Taylor, J. A., Mayordomo, J. I., Jacobs, K. B., Kogevinas, M., Hutchinson, A., Wang, Z., Fu, Y. P., Prokunina-Olsson, L., Burdett, L., Yeager, M., Wheeler, W., Tardón, A., Serra, C., Carrato, A., García-Closas, R., Lloreta, J., Johnson, A., Schwenn, M., Karagas, M. R., Schned, A., Andriole, G., Jr., Grubb, R., III, Black, A., Jacobs, E. J., Diver, W. R., Gapstur, S. M., Weinstein, S. J., Virtamo, J., Cortessis, V. K., Gago-Dominguez, M., Pike, M. C., Stern, M. C., Yuan, J. M., Hunter, D. J., McGrath, M., Dinney, C. P., Czerniak, B., Chen, M., Yang, H., Vermeulen, S. H., Aben, K. K., Witjes, J. A., Makkinje, R. R., Sulem, P., Besenbacher, S., Stefansson, K., Riboli, E., Brennan, P., Panico, S., Navarro, C., Allen, N. E., Bueno-de-Mesquita, H. B., Trichopoulos, D., Caporaso, N., Landi, M. T., Canzian, F., Ljungberg, B., Tjonneland, A., Clavel-Chapelon, F., Bishop, D. T., Teo, M. T., Knowles, M. A., Guarrera, S., Polidoro, S., Ricceri, F., Sacerdote, C., Allione, A., Cancel-Tassin, G., Selinski, S., Hengstler, J. G., Dietrich, H., Fletcher, T., Rudnai, P., Gurzau, E., Koppova, K., Bolick, S. C., Godfrey, A., Xu, Z., Sanz-Velez, J. I., García-Prats, M. D., Sanchez, M., Valdivia, G., Porru S., Benhamou, S., Hoover, R. N., Fraumeni, J. F., Jr., Silverman, D. T., and Chanock, S. J. 2010. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat. Genet. 42: 978–983.
   PubMed Web of Science ®Google Scholar
• Ruiz, J. D., Martínez, C., Anderson, K., Gross, M., Lang, N. P., García-Martín, E., and Agúndez, J. A. 2012. The differential effect of NAT2 variant alleles permits refinement in phenotype inference and identifies a very slow acetylation genotype. PLoS One 7: e44629.
   PubMed Web of Science ®Google Scholar
• Rushton, L., Hutchings, S. J., Fortunato, L., Young, C., Evans, G. S., Brown, T., Bevan, R., Slack, R., Holmes, P., Bagga, S., Cherrie, J. W., and Van Tongeren, M. 2012. Occupational cancer burden in Great Britain. Br. J. Cancer 107(Suppl 1): S3–S7.
   PubMed Web of Science ®Google Scholar
• SAS/STAT® software, version 9.2. Copyright © 2002–2008. Cary, NC: SAS Institute Inc.
   Google Scholar
• Schifflers, E., Jamart, J., and Renard, V. 1987. Tobacco and occupation as risk factors in bladder cancer: A case-control study in southern Belgium. Int. J. Cancer 39: 287–392.
   PubMed Web of Science ®Google Scholar
• Selinski, S., Blaszkewicz, M., Ickstadt, K., Hengstler, J. G., and Golka, K. 2013. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk. Arch. Toxicol. 87: 2129–2139.
   PubMed Web of Science ®Google Scholar
• Selinski, S., Lehmann, M. L., Blaszkewicz, M., Ovsiannikov, D., Moormann, O., Guballa, C., Kress, A., Truss, M. C., Gerullis, H., Otto, T., Barski, D., Niegisch, G., Albers, P., Frees, S., Brenner, W., Thüroff, J. W., Angeli-Greaves, M., Seidel, T., Roth, G., Volkert, F., Ebbinghaus, R., Prager, H. M., Bolt, H. M., Falkenstein, M., Zimmermann, A., Klein, T., Reckwitz, T., Roemer, H. C., Hartel, M., Weistenhöfer, W., Schöps, W., Rizvi, S. A., Aslam, M., Bánfi, G., Romics, I., Ickstadt, K., Hengstler, J. G., and Golka, K. 2012. Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk. Arch. Toxicol. 86: 1369–1378.
   PubMed Web of Science ®Google Scholar
• Selinski, S. 2014. Urinary bladder cancer risk variants: Recent findings and new challenges of GWAS and confirmatory studies. Arch. Toxicol. 88: 1469–1475.
   PubMed Web of Science ®Google Scholar
• Sharp, L., Donnelly, D., Hegarty, A., Carsin, A. E., Deady, S., McCluskey, N., Gavin, A., and Comber, H. 2014. Risk of several cancers is higher in urban areas after adjusting for socioeconomic status. Results from a two-country population-based study of 18 common cancers. J. Urban Health 91: 510–525.
   PubMed Web of Science ®Google Scholar
• SNPedia. 2015. Available at http://www.snpedia.com/index.php/Rs11892031 (accessed August 21, 2015).
   Google Scholar
• Stephens, M., and Donnelly, P. 2003. A comparison of Bayesian methods for haplotype reconstruction. Am. J. Human Genet. 73: 1162–1169.
   PubMed Web of Science ®Google Scholar
• Stephens, M., Smith, N. J., and Donnelly, P. 2001. A new statistical method for haplotype reconstruction from population data. Am. J. Human Genet. 68: 978–989.
   PubMed Web of Science ®Google Scholar
• Weistenhöfer, W., Blaszkewicz, M., Bolt, H. M., and Golka K. 2008. N-Acetyltransferase-2 and medical history in bladder cancer cases with a suspected occupational disease (BK 1301) in Germany. J. Toxicol. Environ. Health A 71: 906–910.
   PubMed Web of Science ®Google Scholar
• Wynder, E. L., Onderdonk, J., and Mantel, N. 1963. An epidemiological investigation of cancer of the bladder. Cancer 16: 1388–1407.
   PubMed Web of Science ®Google Scholar
• Zhang, R., Xu, G., Chen, W., and Zhang, W. 2011. Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: A meta-analysis of 26 studies. Mol. Biol. Rep. 38: 2491–2497.
   PubMed Web of Science ®Google Scholar
• Zimmermann, A., Blaszkewicz, M., Roth, G., Seidel, T., Dietrich, H., Schutschkow, O., Bolt, H. M., and Golka, K. 2008. UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism in bladder cancer cases. J. Toxicol. Environ. Health A 71: 911–914.
   PubMed Web of Science ®Google Scholar